Typicality: | 0.644 |
Saliency: | 0.620 |
for three months | 20 | temporal |
for 5 years | 13 | temporal |
for 12 weeks | 10 | temporal |
subject → receive → placebo | 314 |
subject → receive → the placebo | 26 |
subject → received → placebo | 7 |
subject → received → the placebo | 5 |
negative | neutral | positive |
0.155 | 0.728 | 0.118 |
Raw frequency | 352 |
Normalized frequency | 0.620 |
Modifier score | 0.900 |
Perplexity | 204.924 |